{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:53:42Z","timestamp":1792122822123,"version":"4.4.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF190844"],"award-info":[{"award-number":["IF190844"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["201610039436"],"award-info":[{"award-number":["201610039436"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR24504\/NER\/95\/746\/2017"],"award-info":[{"award-number":["BT\/PR24504\/NER\/95\/746\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/11(35)\/2019"],"award-info":[{"award-number":["ISRM\/11(35)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Malaria is a vector-borne parasitic disease caused by the apicomplexan protozoan parasite\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    . Malaria is a significant health problem and the leading cause of socioeconomic losses in developing countries. WHO approved several antimalarials in the last 2 decades, but the growing resistance against the available drugs has worsened the scenario. Drug resistance and diversity among\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    strains hinder the path of eradicating malaria leading to the use of new technologies and strategies to develop effective vaccines and drugs. A timely and accurate diagnosis is crucial for any disease, including malaria. The available diagnostic methods for malaria include microscopy, RDT, PCR, and non-invasive diagnosis. Recently, there have been several developments in detecting malaria, with improvements leading to achieving an accurate, quick, cost-effective, and non-invasive diagnostic tool for malaria. Several vaccine candidates with new methods and antigens are under investigation and moving forward to be considered for clinical trials. This article concisely reviews basic malaria biology, the parasite's life cycle, approved drugs, vaccine candidates, and available diagnostic approaches. It emphasizes new avenues of therapeutics for malaria.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13071-023-05755-8","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T11:02:13Z","timestamp":1681470133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Malaria therapeutics: are we close enough?"],"prefix":"10.1186","volume":"16","author":[{"given":"Himani","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preshita","family":"Bhalerao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader Saud","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summya","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Raghibul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"5755_CR1","volume-title":"Optimizing public health strategies in low-income countries: the challenges to apply the scientific knowledge for disease control and for which diseases","author":"B Roche","year":"2018","unstructured":"Roche B, Broutin H, Simard F. Optimizing public health strategies in low-income countries: the challenges to apply the scientific knowledge for disease control and for which diseases. Oxford: Oxford University Press; 2018."},{"key":"5755_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2172-1","volume":"17","author":"A Animut","year":"2018","unstructured":"Animut A, Lindtj\u00f8rn B. Use of epidemiological and entomological tools in the control and elimination of malaria in Ethiopia. Malar J. 2018;17:1\u20138.","journal-title":"Malar J"},{"key":"5755_CR3","doi-asserted-by":"publisher","first-page":"3901409","DOI":"10.1155\/2020\/3901409","volume":"2020","author":"RO Makanjuola","year":"2020","unstructured":"Makanjuola RO, Taylor-Robinson AW. Improving accuracy of malaria diagnosis in underserved rural and remote endemic areas of Sub-Saharan Africa: a call to develop multiplexing rapid diagnostic tests. Scientifica. 2020;2020:3901409.","journal-title":"Scientifica"},{"key":"5755_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fmicb.2016.00194","volume":"7","author":"R Soni","year":"2016","unstructured":"Soni R, Sharma D, Bhatt TK. Plasmodium falciparum secretome in erythrocyte and beyond. Front Microbiol. 2016;7:194.","journal-title":"Front Microbiol"},{"key":"5755_CR5","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1039\/D0TB01398F","volume":"8","author":"LN Borgheti-Cardoso","year":"2020","unstructured":"Borgheti-Cardoso LN, Anselmo MS, Lantero E, Lancelot A, Serrano JL, Hern\u00e1ndez-Ainsa S, et al. Promising nanomaterials in the fight against malaria. J Mater Chem B. 2020;8:9428\u201348.","journal-title":"J Mater Chem B"},{"key":"5755_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41541-021-00401-9","volume":"6","author":"Y Keleta","year":"2021","unstructured":"Keleta Y, Ramelow J, Cui L, Li J. Molecular interactions between parasite and mosquito during midgut invasion as targets to block malaria transmission. NPJ Vaccines. 2021;6:140.","journal-title":"NPJ Vaccines"},{"key":"5755_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/vaccines6010013","volume":"6","author":"P Kalantari","year":"2018","unstructured":"Kalantari P. The emerging role of pattern recognition receptors in the pathogenesis of malaria. Vaccines. 2018;6:13.","journal-title":"Vaccines"},{"key":"5755_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-021-03684-z","volume":"595","author":"A Mwakingwe-Omari","year":"2021","unstructured":"Mwakingwe-Omari A, Healy SA, Lane J, Cook DM, Kalhori S, Wyatt C, et al. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. Nature. 2021;595:289\u201394.","journal-title":"Nature"},{"key":"5755_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm.3077","volume":"19","author":"PL Alonso","year":"2013","unstructured":"Alonso PL, Tanner M. Public health challenges and prospects for malaria control and elimination. Nat Med. 2013;19:150\u20135.","journal-title":"Nat Med"},{"key":"5755_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4467-4","volume":"19","author":"F Camponovo","year":"2019","unstructured":"Camponovo F, Ockenhouse CF, Lee C, Penny MA. Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study. BMC Infect Dis. 2019;19:1\u201315.","journal-title":"BMC Infect Dis"},{"key":"5755_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","volume":"24","author":"SJ Draper","year":"2018","unstructured":"Draper SJ, Sack BK, King CR, Nielsen CM, Rayner JC, Higgins MK, et al. Malaria vaccines: recent advances and new horizons. Cell Host Microbe. 2018;24:43\u201356.","journal-title":"Cell Host Microbe"},{"key":"5755_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1756-3305-6-278","volume":"6","author":"SM Abay","year":"2013","unstructured":"Abay SM. Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis. Parasit Vectors. 2013;6:278.","journal-title":"Parasit Vectors"},{"key":"5755_CR13","doi-asserted-by":"crossref","unstructured":"Talapko, \u0160krlec, Alebi\u0107, Juki\u0107, V\u010dev. Malaria: the past and the present. Microorganisms. 2019;7:179.","DOI":"10.3390\/microorganisms7060179"},{"key":"5755_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/IJN.S190692","volume":"14","author":"K Rahman","year":"2019","unstructured":"Rahman K, Khan SU, Fahad S, Chang MX, Abbas A, Khan WU, et al. Nano-biotechnology: a new approach to treat and prevent malaria. Int J Nanomedicine. 2019;14:1401\u201310.","journal-title":"Int J Nanomedicine"},{"key":"5755_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1586\/ecp.09.28","volume":"2","author":"A Alam","year":"2009","unstructured":"Alam A, Goyal M, Iqbal MS, Pal C, Dey S, Bindu S, et al. Novel antimalarial drug targets: hope for new antimalarial drugs. Expert Rev Clin Pharmacol. 2009;2:469\u201389.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5755_CR16","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1039\/c3ra42513d","volume":"4","author":"N Yadav","year":"2014","unstructured":"Yadav N, Sharma C, Awasthi SK. Diversification in the synthesis of antimalarial trioxane and tetraoxane analogs. RSC Adv. 2014;4:5469\u201398.","journal-title":"RSC Adv"},{"key":"5755_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-021-05106-5","volume":"14","author":"S Chakraborti","year":"2021","unstructured":"Chakraborti S, Chhibber-Goel J, Sharma A. Drug targeting of aminoacyl-tRNA synthetases in Anopheles species and Aedes aegypti that cause malaria and dengue. Parasit Vectors. 2021;14:1\u201311.","journal-title":"Parasit Vectors"},{"key":"5755_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2724-z","volume":"18","author":"EG Tse","year":"2019","unstructured":"Tse EG, Korsik M, Todd MH. The past, present and future of anti-malarial medicines. Malar J. 2019;18:1\u201321.","journal-title":"Malar J"},{"key":"5755_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJM199609123351107","volume":"335","author":"NJ White","year":"1996","unstructured":"White NJ. The treatment of malaria. N Engl J Med. 1996;335:800\u20136.","journal-title":"N Engl J Med"},{"key":"5755_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-021-03745-8","volume":"20","author":"A Abamecha","year":"2021","unstructured":"Abamecha A, Yilma D, Adissu W, Yewhalaw D, Abdissa A. Efficacy and safety of artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis. Malar J. 2021;20:213.","journal-title":"Malar J"},{"key":"5755_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nature01813","volume":"424","author":"U Eckstein-Ludwig","year":"2003","unstructured":"Eckstein-Ludwig U, Webb RJ, van Goethem IDA, East JM, Lee AG, Kimura M, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 2003;424:957\u201361.","journal-title":"Nature"},{"key":"5755_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jac\/dks504","volume":"68","author":"GL Nixon","year":"2013","unstructured":"Nixon GL, Moss DM, Shone AE, Lalloo DG, Fisher N, O\u2019Neill PM, et al. Antimalarial pharmacology and therapeutics of atovaquone. J Antimicrob Chemother. 2013;68:977\u201385.","journal-title":"J Antimicrob Chemother"},{"key":"5755_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.coi.2020.07.005","volume":"66","author":"C Coban","year":"2020","unstructured":"Coban C. The host targeting effect of chloroquine in malaria. Curr Opin Immunol. 2020;66:98\u2013107.","journal-title":"Curr Opin Immunol"},{"key":"5755_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-11-2","volume":"11","author":"CO Obonyo","year":"2012","unstructured":"Obonyo CO, Juma EA. Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis. Malar J. 2012;11:1\u201311.","journal-title":"Malar J"},{"key":"5755_CR25","first-page":"e60246","volume":"9","author":"M Okada","year":"2020","unstructured":"Okada M, Guo P, Nalder S, Sigala PA. Doxycycline has distinct apicoplast-specific mechanisms of antimalarial activity. Life. 2020;9:e60246.","journal-title":"Life"},{"key":"5755_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00210972","volume":"71","author":"HD Nothdurft","year":"1993","unstructured":"Nothdurft HD, Clemens R, Bock HL, L\u00f6scher T. Halofantrine: a new substance for treatment of multidrug-resistant malaria. J Clin Investig. 1993;71:69\u201373.","journal-title":"J Clin Investig"},{"key":"5755_CR27","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/jac\/dkv018","volume":"70","author":"MdAA Al-Bari","year":"2015","unstructured":"Al-Bari MdAA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015;70:1608\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"5755_CR28","doi-asserted-by":"publisher","first-page":"e1325","DOI":"10.1371\/journal.pntd.0001325","volume":"5","author":"Q Bassat","year":"2011","unstructured":"Bassat Q. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria. PLOS Negl Trop Dis. 2011;5:e1325.","journal-title":"PLOS Negl Trop Dis"},{"key":"5755_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.31","volume":"2","author":"W Wong","year":"2017","unstructured":"Wong W, Bai X-C, Sleebs BE, Triglia T, Brown A, Thompson JK, et al. Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat Microbiol. 2017;2:1\u20139.","journal-title":"Nat Microbiol"},{"key":"5755_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-5-84","volume":"5","author":"PE Meissner","year":"2006","unstructured":"Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, et al. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar J. 2006;5:1\u20135.","journal-title":"Malar J"},{"key":"5755_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","volume":"65","author":"TME Davis","year":"2005","unstructured":"Davis TME, Hung T-Y, Sim I-K, Karunajeewa HA, Ilett KF. Piperaquine A Resurgent Antimalarial Drug. Drugs. 2005;65:75\u201387.","journal-title":"Drugs"},{"key":"5755_CR32","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/424663","volume":"39","author":"JK Baird","year":"2004","unstructured":"Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis. 2004;39:1336\u201345.","journal-title":"Clin Infect Dis"},{"key":"5755_CR33","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1128\/AAC.43.6.1334","volume":"43","author":"IK Srivastava","year":"1999","unstructured":"Srivastava IK, Vaidya AB. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother. 1999;43:1334\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5755_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2165\/00002018-200730060-00003","volume":"30","author":"PJ Peters","year":"2007","unstructured":"Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine\/pyrimethamine. Drug Saf. 2007;30:481\u2013501.","journal-title":"Drug Saf"},{"key":"5755_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23398","volume":"112","author":"C Bailly","year":"2021","unstructured":"Bailly C. Pyronaridine: an update of its pharmacological activities and mechanisms of action. Biopolymers. 2021;112:e23398.","journal-title":"Biopolymers"},{"key":"5755_CR36","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1126\/science.169.3944.492","volume":"169","author":"K van Dyke","year":"1970","unstructured":"van Dyke K, Lantz C, Szustkiewicz C. Quinacrine: mechanisms of antimalarial action. Science. 1970;169:492\u20133.","journal-title":"Science"},{"key":"5755_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1365-2958.2008.06108.x","volume":"67","author":"CP Sanchez","year":"2008","unstructured":"Sanchez CP, Stein WD, Lanzer M. Dissecting the components of quinine accumulation in Plasmodium falciparum. Mol Microbiol. 2008;67:1081\u201393.","journal-title":"Mol Microbiol"},{"key":"5755_CR38","volume-title":"Antiprotozoal Drugs Encyclopedia of Molecular Pharmacology","author":"T Junghanss","year":"2008","unstructured":"Junghanss T, Lanzer M. Antiprotozoal Drugs Encyclopedia of Molecular Pharmacology. Berlin: Springer; 2008."},{"key":"5755_CR39","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2147\/DDDT.S61443","volume":"10","author":"YA Ebstie","year":"2016","unstructured":"Ebstie YA, Abay SM, Tadesse WT, A. Ejigu D. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date. Drug Des Devel Ther. 2016;10:2387\u201399.","journal-title":"Drug Des Devel Ther"},{"key":"5755_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.22506\/ti\/2016\/v23\/i2\/146684","volume":"23","author":"EO Erhirhie","year":"2016","unstructured":"Erhirhie EO. Antimalarial therapies and infertility: a comprehensive review. Toxicol Int. 2016;23:107\u201311.","journal-title":"Toxicol Int"},{"key":"5755_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-10-644","volume":"10","author":"TK Bhatt","year":"2009","unstructured":"Bhatt TK, Kapil C, Khan S, Jairajpuri MA, Sharma V, Santoni D, et al. A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum. BMC Genom. 2009;10:1\u20134.","journal-title":"BMC Genom"},{"key":"5755_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.chembiol.2021.07.010","volume":"29","author":"RL Summers","year":"2022","unstructured":"Summers RL, Pasaje CFA, Pisco JP, Striepen J, Luth MR, Kumpornsin K, et al. Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. Cell Chem Biol. 2022;29:191\u2013201.","journal-title":"Cell Chem Biol"},{"key":"5755_CR43","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","volume":"7","author":"B Forte","year":"2021","unstructured":"Forte B, Ottilie S, Plater A, Campo B, Dechering KJ, Gamo FJ, et al. Prioritization of molecular targets for antimalarial drug discovery. ACS Infect Dis. 2021;7:2764\u201376.","journal-title":"ACS Infect Dis"},{"key":"5755_CR44","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.drudis.2018.01.050","volume":"23","author":"Y Manickam","year":"2018","unstructured":"Manickam Y, Chaturvedi R, Babbar P, Malhotra N, Jain V, Sharma A. Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum. Drug Discov Today. 2018;23:1233\u201340.","journal-title":"Drug Discov Today"},{"key":"5755_CR45","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jmb.2010.11.018","volume":"405","author":"C Wrenger","year":"2011","unstructured":"Wrenger C, M\u00fcller IB, Schifferdecker AJ, Jain R, Jordanova R, Groves MR. Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum. J Mol Biol. 2011;405:956\u201371.","journal-title":"J Mol Biol"},{"key":"5755_CR46","first-page":"232","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Kr\u00fcger A, Du X, Wrenger C, Groves MR. Novel highlight in malarial drug discovery: aspartate transcarbamoylase. Front Cell Infect Microbiol. 2022;12:232.","journal-title":"Front Cell Infect Microbiol"},{"key":"5755_CR47","doi-asserted-by":"publisher","DOI":"10.5772\/65659","author":"S Lunev","year":"2016","unstructured":"Lunev S, Batista FA, Bosch SS, Wrenger C, Groves MR. Identification and validation of novel drug targets for the treatment of Plasmodium falciparum malaria: new insights. Current Topics Malaria. 2016. https:\/\/doi.org\/10.5772\/65659.","journal-title":"Current Topics Malaria"},{"key":"5755_CR48","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1074\/jbc.M112.411934","volume":"288","author":"A Bansal","year":"2013","unstructured":"Bansal A, Singh S, More KR, Hans D, Nangalia K, Yogavel M, et al. Characterization of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) and its role in microneme secretion during erythrocyte invasion. J Biol Chem. 2013;288:1590\u2013602.","journal-title":"J Biol Chem"},{"key":"5755_CR49","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2174\/156802611796575948","volume":"11","author":"M Belen Cassera","year":"2011","unstructured":"Belen Cassera M, Zhang Y, Hazleton ZK, Schramm LV. Purine and pyrimidine pathways as targets in Plasmodium falciparum. Curr Top Med Chem. 2011;11:2103\u201315.","journal-title":"Curr Top Med Chem"},{"key":"5755_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2221-1691(11)60034-8","volume":"1","author":"SR Krungkrai","year":"2011","unstructured":"Krungkrai SR, Krungkrai J. Malaria parasite carbonic anhydrase: inhibition of aromatic\/heterocyclic sulfonamides and its therapeutic potential. Asian Pac j trop med. 2011;1:233\u201342.","journal-title":"Asian Pac j trop med"},{"key":"5755_CR51","doi-asserted-by":"publisher","first-page":"e85391","DOI":"10.1371\/journal.pone.0085391","volume":"9","author":"M Graciotti","year":"2014","unstructured":"Graciotti M, Alam M, Solyakov L, Schmid R, Burley G, Bottrill AR, et al. Malaria protein kinase CK2 (PfCK2) shows novel mechanisms of regulation. PLoS ONE. 2014;9:e85391.","journal-title":"PLoS ONE"},{"key":"5755_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.610408","volume":"11","author":"D Rotella","year":"2021","unstructured":"Rotella D, Siekierka J, Bhanot P. Plasmodium falciparum cGMP-dependent protein kinase \u2013 A novel chemotherapeutic target. Front Microbiol. 2021;11:610408.","journal-title":"Front Microbiol"},{"key":"5755_CR53","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1128\/AAC.00919-06","volume":"51","author":"V Choubey","year":"2007","unstructured":"Choubey V, Maity P, Guha M, Kumar S, Srivastava K, Puri SK, et al. Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism. Antimicrob Agents Chemother. 2007;51:696\u2013706.","journal-title":"Antimicrob Agents Chemother"},{"key":"5755_CR54","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/s41598-018-29500-9","volume":"8","author":"E Guca","year":"2018","unstructured":"Guca E, Nagy GN, Hajd\u00fa F, Marton L, Izrael R, Hoh F, et al. Structural determinants of the catalytic mechanism of Plasmodium CCT, a key enzyme of malaria lipid biosynthesis. Sci Rep. 2018;8:11215.","journal-title":"Sci Rep"},{"key":"5755_CR55","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2174\/1381612023394197","volume":"8","author":"P Rosenthal","year":"2002","unstructured":"Rosenthal P, Sijwali P, Singh A, Shenai B. Cysteine proteases of malaria parasites: targets for chemotherapy. Curr Pharm Des. 2002;8:1659\u201372.","journal-title":"Curr Pharm Des"},{"key":"5755_CR56","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4155\/fmc.13.121","volume":"5","author":"GL Nixon","year":"2013","unstructured":"Nixon GL, Pidathala C, Shone AE, Antoine T, Fisher N, O\u2019Neill PM, et al. Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era. Future Med Chem. 2013;5:1573\u201391.","journal-title":"Future Med Chem"},{"key":"5755_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3923\/ajcb.2006.48.58","volume":"1","author":"R Mishra","year":"2005","unstructured":"Mishra R, Mishra B, Moorthy NH. Dihydrofolate reductase enzyme: a potent target for antimalarial research. Asian J Cell Biol. 2005;1:48\u201358.","journal-title":"Asian J Cell Biol"},{"key":"5755_CR58","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1128\/AAC.01835-15","volume":"60","author":"W Pornthanakasem","year":"2016","unstructured":"Pornthanakasem W, Riangrungroj P, Chitnumsub P, Ittarat W, Kongkasuriyachai D, Uthaipibull C, et al. Role of Plasmodium vivax dihydropteroate synthase polymorphisms in sulfa drug resistance. Antimicrob Agents Chemother. 2016;60:4453\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"5755_CR59","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1128\/AAC.02495-12","volume":"57","author":"TQ Tanaka","year":"2013","unstructured":"Tanaka TQ, Deu E, Molina-Cruz A, Ashburne MJ, Ali O, Suri A, et al. Plasmodium dipeptidyl aminopeptidases as malaria transmission-blocking drug targets. Antimicrob Agents Chemother. 2013;57:4645\u201352.","journal-title":"Antimicrob Agents Chemother"},{"key":"5755_CR60","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.3390\/molecules26185711","volume":"26","author":"CL Koumpoura","year":"2021","unstructured":"Koumpoura CL, Robert A, Athanassopoulos CM, Baltas M. Antimalarial inhibitors targeting epigenetics or mitochondria in Plasmodium falciparum: recent survey upon synthesis and biological evaluation of potential drugs against malaria. Molecules. 2021;26:5711.","journal-title":"Molecules"},{"key":"5755_CR61","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.2147\/DDDT.S265602","volume":"14","author":"TM Belete","year":"2020","unstructured":"Belete TM. Recent progress in the development of new antimalarial drugs with novel targets. Drug Des Devel Ther. 2020;14:3875\u201389.","journal-title":"Drug Des Devel Ther"},{"key":"5755_CR62","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/156802612799362913","volume":"12","author":"M Marco","year":"2012","unstructured":"Marco M, Miguel CJ. Falcipain inhibition as a promising antimalarial target. Curr Top Med Chem. 2012;12:408\u201344.","journal-title":"Curr Top Med Chem"},{"key":"5755_CR63","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2174\/1389450117666160823165004","volume":"18","author":"K Sharma","year":"2017","unstructured":"Sharma K. A Review on Plasmodium falciparum-protein farnesyltransferase inhibitors as antimalarial drug targets. Curr Drug Targets. 2017;18:1676\u201386.","journal-title":"Curr Drug Targets"},{"key":"5755_CR64","doi-asserted-by":"publisher","first-page":"55a","DOI":"10.1016\/j.bpj.2014.11.337","volume":"108","author":"S Lim","year":"2015","unstructured":"Lim S, Prieto JH. Glutathione reductase of Plasmodium falciparum as an antimalarial drug target of methylene blue. Biophys J. 2015;108:55a\u20136a.","journal-title":"Biophys J"},{"key":"5755_CR65","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fphar.2020.00246","volume":"11","author":"EE Col\u00f3n-Lorenzo","year":"2020","unstructured":"Col\u00f3n-Lorenzo EE, Col\u00f3n-L\u00f3pez DD, Vega-Rodr\u00edguez J, Dupin A, Fidock DA, Baerga-Ortiz A, et al. Structure-based screening of Plasmodium berghei glutathione S-transferase identifies CB-27 as a novel antiplasmodial compound. Front Pharmacol. 2020;11:246.","journal-title":"Front Pharmacol"},{"key":"5755_CR66","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1021\/jm500747h","volume":"57","author":"S Bruno","year":"2014","unstructured":"Bruno S, Pinto A, Paredi G, Tamborini L, de Micheli C, la Pietra V, et al. Discovery of covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase, a target for the treatment of malaria. J Med Chem. 2014;57:7465\u201371.","journal-title":"J Med Chem"},{"key":"5755_CR67","first-page":"451065","volume":"2014","author":"A Alam","year":"2014","unstructured":"Alam A, Neyaz MK, Ikramul Hasan S. Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development. Malar Res Treat. 2014;2014:451065.","journal-title":"Malar Res Treat"},{"key":"5755_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-2-30","volume":"2","author":"R Kumar","year":"2003","unstructured":"Kumar R, Musiyenko A, Barik S. The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin. Malar J. 2003;2:1\u201311.","journal-title":"Malar J"},{"key":"5755_CR69","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4155\/fmc.13.113","volume":"5","author":"KY Fong","year":"2013","unstructured":"Fong KY, Wright DW. Hemozoin and antimalarial drug discovery. Future Med Chem. 2013;5:1437\u201350.","journal-title":"Future Med Chem"},{"key":"5755_CR70","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.1073\/pnas.1330865100","volume":"100","author":"T Jo\u00ebt","year":"2003","unstructured":"Jo\u00ebt T, Eckstein-Ludwig U, Morin C, Krishna S. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Proc Natl Acad Sci. 2003;100:7476\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"5755_CR71","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1021\/jm801654y","volume":"52","author":"V Patel","year":"2009","unstructured":"Patel V, Mazitschek R, Coleman B, Nguyen C, Urgaonkar S, Cortese J, et al. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J Med Chem. 2009;52:2185\u20137.","journal-title":"J Med Chem"},{"key":"5755_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009351","volume":"17","author":"J Miao","year":"2021","unstructured":"Miao J, Wang C, Lucky AB, Liang X, Min H, Adapa SR, et al. A unique GCN5 histone acetyltransferase complex controls erythrocyte invasion and virulence in the malaria parasite Plasmodium falciparum. PLoS Pathog. 2021;17:e1009351.","journal-title":"PLoS Pathog"},{"key":"5755_CR73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molbiopara.2010.05.018","volume":"173","author":"DT Keough","year":"2010","unstructured":"Keough DT, Hockov\u00e1 D, Kre\u010dmerov\u00e1 M, \u010cesnek M, Hol\u00fd A, Naesens L, et al. Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase: a target for anti-malarial chemotherapy. Mol Biochem Parasitol. 2010;173:165\u20139.","journal-title":"Mol Biochem Parasitol"},{"key":"5755_CR74","doi-asserted-by":"publisher","first-page":"e21237","DOI":"10.1371\/journal.pone.0021237","volume":"6","author":"J Penna-Coutinho","year":"2011","unstructured":"Penna-Coutinho J, Cortopassi WA, Oliveira AA, Fran\u00e7a TCC, Krettli AU. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies. PLoS ONE. 2011;6:e21237.","journal-title":"PLoS ONE"},{"key":"5755_CR75","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s42003-021-02442-1","volume":"4","author":"A Reyes Romero","year":"2021","unstructured":"Reyes Romero A, Lunev S, Popowicz GM, Calderone V, Gentili M, Sattler M, et al. A fragment-based approach identifies an allosteric pocket that impacts malate dehydrogenase activity. Commun Biol. 2021;4:949.","journal-title":"Commun Biol"},{"key":"5755_CR76","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbabio.2017.12.004","volume":"1859","author":"ED Hartuti","year":"2018","unstructured":"Hartuti ED, Inaoka DK, Komatsuya K, Miyazaki Y, Miller RJ, Xinying W, et al. Biochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate:quinone oxidoreductase, a potential drug target. Biochim Biophys Acta Bioenerg. 2018;1859:191\u2013200.","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"5755_CR77","doi-asserted-by":"publisher","first-page":"14548","DOI":"10.1073\/pnas.0604101103","volume":"103","author":"X Chen","year":"2006","unstructured":"Chen X, Chong CR, Shi L, Yoshimoto T, Sullivan DJ, Liu JO. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity. Proc Natl Acad Sci. 2006;103:14548\u201353.","journal-title":"Proc Natl Acad Sci"},{"key":"5755_CR78","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1365-2958.2007.05859.x","volume":"65","author":"D Dorin-Semblat","year":"2007","unstructured":"Dorin-Semblat D, Quashie N, Halbert J, Sicard A, Doerig C, Peat E, et al. Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics. Mol Microbiol. 2007;65:1170\u201380.","journal-title":"Mol Microbiol"},{"key":"5755_CR79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/acsinfecdis.7b00203","volume":"4","author":"AC Schlott","year":"2018","unstructured":"Schlott AC, Holder AA, Tate EW. N -myristoylation as a drug target in malaria: exploring the role of N -myristoyltransferase substrates in the inhibitor mode of action. ACS Infect Dis. 2018;4:449\u201357.","journal-title":"ACS Infect Dis"},{"key":"5755_CR80","doi-asserted-by":"publisher","first-page":"e0214023","DOI":"10.1371\/journal.pone.0214023","volume":"14","author":"H Ke","year":"2019","unstructured":"Ke H, Ganesan SM, Dass S, Morrisey JM, Pou S, Nilsen A, et al. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages. PLoS ONE. 2019;14:e0214023.","journal-title":"PLoS ONE"},{"key":"5755_CR81","doi-asserted-by":"publisher","first-page":"e40529","DOI":"10.7554\/eLife.40529","volume":"8","author":"ES Istvan","year":"2019","unstructured":"Istvan ES, Das S, Bhatnagar S, Beck JR, Owen E, Llinas M, et al. Plasmodium Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasis. eLife. 2019;8:e40529.","journal-title":"eLife"},{"key":"5755_CR82","volume-title":"Plasmodium species and drug resistance","author":"MX Henry","year":"2021","unstructured":"Henry MX. A double line of defense: heat shock proteins and polyamines act as contributing factors to drug resistance of some Plasmodium parasites. In: Tyagi RK, editor. Plasmodium species and drug resistance. London: IntechOpen; 2021."},{"key":"5755_CR83","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1107\/S2053230X1500549X","volume":"71","author":"S Kumar","year":"2015","unstructured":"Kumar S, Krishnamoorthy K, Mudeppa DG, Rathod PK. Structure of Plasmodium falciparum orotate phosphoribosyltransferase with autologous inhibitory protein\u2013protein interactions. Acta Crystallogr F Struct Biol Commun. 2015;71:600\u20138.","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"5755_CR84","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1021\/bi048439h","volume":"44","author":"SR Krungkrai","year":"2005","unstructured":"Krungkrai SR, DelFraino BJ, Smiley JA, Prapunwattana P, Mitamura T, Horii T, et al. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5\u2018-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization. Biochemistry. 2005;44:1643\u201352.","journal-title":"Biochemistry"},{"key":"5755_CR85","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1600-079X.2012.00981.x","volume":"53","author":"FC Koyama","year":"2012","unstructured":"Koyama FC, Ribeiro RY, Garcia JL, Azevedo MF, Chakrabarti D, Garcia CRS. Ubiquitin proteasome system and the atypical kinase PfPK7 are involved in melatonin signaling in Plasmodium falciparum. J Pineal Res. 2012;53:147\u201353.","journal-title":"J Pineal Res"},{"key":"5755_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-0673-8","volume":"14","author":"HE Pett","year":"2015","unstructured":"Pett HE, Jansen PA, Hermkens PH, Botman PN, Beuckens-Schortinghuis CA, Blaauw RH, et al. Novel pantothenate derivatives for anti-malarial chemotherapy. Malar J. 2015;14:1\u20138.","journal-title":"Malar J"},{"key":"5755_CR87","doi-asserted-by":"publisher","first-page":"3000154","DOI":"10.1371\/journal.pbio.3000154","volume":"17","author":"C Flueck","year":"2019","unstructured":"Flueck C, Drought LG, Jones A, Patel A, Perrin AJ, Walker EM, et al. Phosphodiesterase beta is the master regulator of cAMP signaling during malaria parasite invasion. PLoS Biol. 2019;17:3000154.","journal-title":"PLoS Biol"},{"key":"5755_CR88","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1021\/acsinfecdis.0c00724","volume":"7","author":"LB Arendse","year":"2021","unstructured":"Arendse LB, Wyllie S, Chibale K, Gilbert IH. Plasmodium kinases as potential drug targets for malaria: challenges and opportunities. ACS Infect Dis. 2021;7:518\u201334.","journal-title":"ACS Infect Dis"},{"key":"5755_CR89","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/EC.00124-10","volume":"9","author":"L Tawk","year":"2010","unstructured":"Tawk L, Chicanne G, Dubremetz J-F, Richard V, Payrastre B, Vial HJ, et al. Phosphatidylinositol 3-phosphate, an essential lipid in Plasmodium, localizes to the food vacuole membrane and the apicoplast. Eukaryot Cell. 2010;9:1519\u201330.","journal-title":"Eukaryot Cell"},{"key":"5755_CR90","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1742-4658.2005.04620.x","volume":"272","author":"J Raman","year":"2005","unstructured":"Raman J, Ashok CS, Subbayya IN, Anand RP, Senthamizh T, Selvi S, et al. Plasmodium falciparum hypoxanthine guanine phosphoribosyltransferase. FEBS J. 2005;272:1900\u201311.","journal-title":"FEBS J"},{"key":"5755_CR91","doi-asserted-by":"publisher","DOI":"10.5772\/66716","author":"P Liu","year":"2017","unstructured":"Liu P. Plasmepsin: function, characterization and targeted antimalarial drug development. Nat Remed Fight Against Parasites. 2017. https:\/\/doi.org\/10.5772\/66716.","journal-title":"Nat Remed Fight Against Parasites"},{"key":"5755_CR92","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/antiox10121872","volume":"10","author":"CO Egwu","year":"2021","unstructured":"Egwu CO, Augereau J-M, Reybier K, Benoit-Vical F. Reactive oxygen species as the brainbox in malaria treatment. Antioxidants. 2021;10:1872.","journal-title":"Antioxidants"},{"key":"5755_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12733","volume":"19","author":"S Ghosh","year":"2017","unstructured":"Ghosh S, Kennedy K, Sanders P, Matthews K, Ralph SA, Counihan NA, et al. The Plasmodium rhoptry associated protein complex is important for parasitophorous vacuole membrane structure and intraerythrocytic parasite growth. Cell Microbiol. 2017;19:e12733.","journal-title":"Cell Microbiol"},{"key":"5755_CR94","first-page":"977","volume":"127","author":"M Nakanishi","year":"2007","unstructured":"Nakanishi M. S-Adenosyl-L-homocysteine hydrolase as an attractive target for antimicrobial drugs. ChemInform. 2007;127:977\u201382.","journal-title":"ChemInform"},{"key":"5755_CR95","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1128\/IAI.00405-07","volume":"75","author":"JE McCoubrie","year":"2007","unstructured":"McCoubrie JE, Miller SK, Sargeant T, Good RT, Hodder AN, Speed TP, et al. Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Infect Immun. 2007;75:5565\u201374.","journal-title":"Infect Immun"},{"key":"5755_CR96","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1128\/EC.00334-08","volume":"8","author":"Z Holland","year":"2009","unstructured":"Holland Z, Prudent R, Reiser J-B, Cochet C, Doerig C. functional analysis of protein kinase ck2 of the human malaria parasite Plasmodium falciparum. Eukaryot Cell. 2009;8:388\u201397.","journal-title":"Eukaryot Cell"},{"key":"5755_CR97","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molbiopara.2007.10.007","volume":"157","author":"R Tuteja","year":"2008","unstructured":"Tuteja R, Pradhan A, Sharma S. Plasmodium falciparum signal peptidase is regulated by phosphorylation and required for intra-erythrocytic growth. Mol Biochem Parasitol. 2008;157:137\u201347.","journal-title":"Mol Biochem Parasitol"},{"key":"5755_CR98","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BCJ20190918","volume":"477","author":"SJ Tarr","year":"2020","unstructured":"Tarr SJ, Withers-Martinez C, Flynn HR, Snijders AP, Masino L, Koussis K, et al. A malaria parasite subtilisin propeptide-like protein is a potent inhibitor of the egress protease SUB1. Biochem J. 2020;477:525\u201340.","journal-title":"Biochem J"},{"key":"5755_CR99","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.parint.2012.06.002","volume":"61","author":"TQ Tanaka","year":"2012","unstructured":"Tanaka TQ, Hirai M, Watanabe Y, Kita K. Toward understanding the role of mitochondrial complex II in the intraerythrocytic stages of Plasmodium falciparum: gene targeting of the Fp subunit. Parasitol Int. 2012;61:726\u20138.","journal-title":"Parasitol Int"},{"key":"5755_CR100","doi-asserted-by":"publisher","first-page":"685866","DOI":"10.3389\/fcimb.2021.685866","volume":"11","author":"D Sumam de Oliveira","year":"2021","unstructured":"Sumam de Oliveira D, Kronenberger T, Palmisano G, Wrenger C, de Souza EE. Targeting SUMOylation in Plasmodium as a potential target for malaria therapy. Front Cell Infect Microbiol. 2021;11:685866.","journal-title":"Front Cell Infect Microbiol"},{"key":"5755_CR101","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1128\/AAC.00057-08","volume":"52","author":"G Lisk","year":"2008","unstructured":"Lisk G, Pain M, Gluzman IY, Kambhampati S, Furuya T, Su X, et al. Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum -infected erythrocytes. Antimicrob Agents Chemother. 2008;52:2346\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"5755_CR102","doi-asserted-by":"publisher","first-page":"40180","DOI":"10.1074\/jbc.M007633200","volume":"275","author":"SM Kanzok","year":"2000","unstructured":"Kanzok SM, Schirmer RH, T\u00fcrbachova I, Iozef R, Becker K. The thioredoxin system of the malaria parasite Plasmodium falciparum. J Biol Chem. 2000;275:40180\u20136.","journal-title":"J Biol Chem"},{"key":"5755_CR103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1017\/S003118200400664X","volume":"130","author":"Y Yuthavong","year":"2005","unstructured":"Yuthavong Y, Yuvaniyama J, Chitnumsub P, Vanichtanankul J, Chusacultanachai S, Tarnchompoo B, et al. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors. Parasitology. 2005;130:249\u201359.","journal-title":"Parasitology"},{"key":"5755_CR104","doi-asserted-by":"publisher","first-page":"20313","DOI":"10.1074\/jbc.M115.639039","volume":"290","author":"DG Mudeppa","year":"2015","unstructured":"Mudeppa DG, Kumar S, Kokkonda S, White J, Rathod PK. Topoisomerase II from human malaria parasites. J Biol Chem. 2015;290:20313\u201324.","journal-title":"J Biol Chem"},{"key":"5755_CR105","doi-asserted-by":"publisher","first-page":"36841","DOI":"10.1074\/jbc.M507727200","volume":"280","author":"N Marchesini","year":"2005","unstructured":"Marchesini N, Vieira M, Luo S, Moreno SNJ, Docampo R. A malaria parasite-encoded vacuolar H+-ATPase is targeted to the host erythrocyte. J Biol Chem. 2005;280:36841\u20137.","journal-title":"J Biol Chem"},{"key":"5755_CR106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","volume":"10","author":"M Moafi","year":"2019","unstructured":"Moafi M, Rezvan H, Sherkat R, Taleban R. Leishmania vaccines entered in clinical trials: a review of literature. Int J Prev Med. 2019;10:95.","journal-title":"Int J Prev Med"},{"key":"5755_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2019.e00053","volume":"15","author":"EA Innes","year":"2019","unstructured":"Innes EA, Hamilton C, Garcia JL, Chryssafidis A, Smith D. A one health approach to vaccines against Toxoplasma gondii. Food Waterborne Parasitol. 2019;15:e00053.","journal-title":"Food Waterborne Parasitol"},{"key":"5755_CR108","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/216160a0","volume":"216","author":"RS Nussenzweig","year":"1967","unstructured":"Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature. 1967;216:160\u20132.","journal-title":"Nature"},{"key":"5755_CR109","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14760584.2016.1203784","volume":"16","author":"MR Hollingdale","year":"2017","unstructured":"Hollingdale MR, Sedegah M. Development of whole sporozoite malaria vaccines. Expert Rev Vaccines. 2017;16:45\u201354.","journal-title":"Expert Rev Vaccines"},{"key":"5755_CR110","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/RMHP.S219294","volume":"14","author":"N Arora","year":"2021","unstructured":"Arora N, Anbalagan LC, Pannu AK. Towards eradication of malaria: is the WHO\u2019s RTS, S\/AS01 vaccination effective enough? Risk Manag Healthc Policy. 2021;14:1033\u20139.","journal-title":"Risk Manag Healthc Policy"},{"key":"5755_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1295381","volume":"1295381","author":"D Nureye","year":"2020","unstructured":"Nureye D, Assefa S. Old and recent advances in life cycle, pathogenesis, diagnosis, prevention, and treatment of malaria including perspectives in Ethiopia. Sci World J. 2020;1295381:1\u201317.","journal-title":"Sci World J"},{"key":"5755_CR112","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/339409","volume":"185","author":"SL Hoffman","year":"2002","unstructured":"Hoffman SL, Goh LML, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002;185:1155\u201364.","journal-title":"J Infect Dis"},{"key":"5755_CR113","doi-asserted-by":"publisher","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","volume":"114","author":"D Oyen","year":"2017","unstructured":"Oyen D, Torres JL, Wille-Reece U, Ockenhouse CF, Emerling D, Glanville J, et al. Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci. 2017;114:E10438-10445.","journal-title":"Proc Natl Acad Sci"},{"key":"5755_CR114","doi-asserted-by":"publisher","first-page":"e72908","DOI":"10.7554\/eLife.72908","volume":"11","author":"I Kucharska","year":"2022","unstructured":"Kucharska I, Hossain L, Ivanochko D, Yang Q, Rubinstein JL, Pom\u00e8s R, et al. Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. eLife. 2022;11:e72908.","journal-title":"eLife"},{"key":"5755_CR115","doi-asserted-by":"publisher","first-page":"e0004423","DOI":"10.1371\/journal.pntd.0004423","volume":"10","author":"JW Bennett","year":"2016","unstructured":"Bennett JW, Yadava A, Tosh D, Sattabongkot J, Komisar J, Ware LA, et al. Phase 1\/2a trial of Plasmodium vivax malaria vaccine candidate VMP001\/AS01B in malaria-naive adults: safety, immunogenicity, and efficacy. PLOS Negl Trop Dis. 2016;10:e0004423.","journal-title":"PLOS Negl Trop Dis"},{"key":"5755_CR116","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nm.4513","volume":"24","author":"J Tan","year":"2018","unstructured":"Tan J, Sack BK, Oyen D, Zenklusen I, Piccoli L, Barbieri S, et al. A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein. Nat Med. 2018;24:401\u20137.","journal-title":"Nat Med"},{"key":"5755_CR117","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202163011","volume":"63","author":"MEM Almeida","year":"2021","unstructured":"Almeida MEM, Vasconcelos MGS, Tarrag\u00f4 AM, Mari\u00faba LAM. Circumsporozoite surface protein-based malaria vaccines: a review. Rev Inst Med Trop Sao Paulo. 2021;63:e11.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5755_CR118","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/vaccines9030272","volume":"9","author":"JR Francica","year":"2021","unstructured":"Francica JR, Shi W, Chuang G-Y, Chen SJ, Pereira LDS, Farney SK, et al. Design of alphavirus virus-like particles presenting circumsporozoite junctional epitopes that elicit protection against malaria. Vaccines. 2021;9:272.","journal-title":"Vaccines"},{"key":"5755_CR119","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, et al. Protection against Plasmodium falciparum malaria by PfSPZ vaccine. JCI Insight. 2017;2:e89154.","journal-title":"JCI Insight"},{"key":"5755_CR120","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1073\/pnas.1615324114","volume":"114","author":"KE Lyke","year":"2017","unstructured":"Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, et al. Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci. 2017;114:2711\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"5755_CR121","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature21060","volume":"542","author":"B Mordm\u00fcller","year":"2017","unstructured":"Mordm\u00fcller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445\u20139.","journal-title":"Nature"},{"key":"5755_CR122","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4269\/ajtmh.20-0435","volume":"104","author":"SA Jongo","year":"2021","unstructured":"Jongo SA, Urbano V, Church LWP, Olotu A, Manock SR, Schindler T, et al. Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in equatoguinean adults. Am J Trop Med Hyg. 2021;104:283\u201393.","journal-title":"Am J Trop Med Hyg"},{"key":"5755_CR123","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1126\/scitranslmed.aaz5629","volume":"12","author":"M Roestenberg","year":"2020","unstructured":"Roestenberg M, Walk J, van der Boor SC, Langenberg MCC, Hoogerwerf M-A, Janse JJ, et al. A double-blind, placebo-controlled phase 1\/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1. Sci Transl Med. 2020;12:5629.","journal-title":"Sci Transl Med"},{"key":"5755_CR124","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1126\/scitranslmed.aad9099","volume":"9","author":"JG Kublin","year":"2017","unstructured":"Kublin JG, Mikolajczak SA, Sack BK, Fishbaugher ME, Seilie A, Shelton L, et al. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects. Sci Transl Med. 2017;9:9099.","journal-title":"Sci Transl Med"},{"key":"5755_CR125","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pt.2016.09.012","volume":"33","author":"M Singer","year":"2017","unstructured":"Singer M, Frischknecht F. Time for genome editing: next-generation attenuated malaria parasites. Trends Parasitol. 2017;33:202\u201313.","journal-title":"Trends Parasitol"},{"key":"5755_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2431-1","volume":"17","author":"C Marin-Mogollon","year":"2018","unstructured":"Marin-Mogollon C, van Pul FJA, Miyazaki S, Imai T, Ramesar J, Salman AM, et al. Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites. Malar J. 2018;17:1\u201316.","journal-title":"Malar J"},{"key":"5755_CR127","unstructured":"World malaria report 2021. WHO. 2022."},{"key":"5755_CR128","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/bit.26890","volume":"116","author":"HKC Hume","year":"2019","unstructured":"Hume HKC, Vidigal J, Carrondo MJT, Middelberg APJ, Rold\u00e3o A, Lua LHL. Synthetic biology for bioengineering virus-like particle vaccines. Biotechnol Bioeng. 2019;116:919\u201335.","journal-title":"Biotechnol Bioeng"},{"key":"5755_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00806-7","volume":"19","author":"S Nooraei","year":"2021","unstructured":"Nooraei S, Bahrulolum H, Hoseini ZS, Katalani C, Hajizade A, Easton AJ, et al. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J Nanobiotechnology. 2021;19:1\u201327.","journal-title":"J Nanobiotechnology"},{"key":"5755_CR130","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","volume":"16","author":"MB Laurens","year":"2020","unstructured":"Laurens MB. RTS, S\/AS01 vaccine (MosquirixTM): an overview. Hum Vaccines Immunother. 2020;16:480\u20139.","journal-title":"Hum Vaccines Immunother"},{"key":"5755_CR131","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","volume":"397","author":"MS Datoo","year":"2021","unstructured":"Datoo MS, Natama MH, Som\u00e9 A, Traor\u00e9 O, Rouamba T, Bellamy D, et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet. 2021;397:1809\u201318.","journal-title":"Lancet"},{"key":"5755_CR132","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41563-018-0256-5","volume":"18","author":"DS Wilson","year":"2019","unstructured":"Wilson DS, Hirosue S, Raczy MM, Bonilla-Ramirez L, Jeanbart L, Wang R, et al. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nat Mater. 2019;18:175\u201385.","journal-title":"Nat Mater"},{"key":"5755_CR133","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14760584.2020.1745636","volume":"19","author":"CR Alving","year":"2020","unstructured":"Alving CR, Peachman KK, Matyas GR, Rao M, Beck Z. Army Liposome Formulation (ALF) family of vaccine adjuvants. Expert Rev Vaccines. 2020;19:279\u201392.","journal-title":"Expert Rev Vaccines"},{"key":"5755_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016333","volume":"6","author":"RN Coler","year":"2011","unstructured":"Coler RN, Bertholet S, Moutaftsi M, Guderian JA, Windish HP, Baldwin SL, et al. Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PLoS ONE. 2011;6:e16333.","journal-title":"PLoS ONE"},{"key":"5755_CR135","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1074\/jbc.M115.683011","volume":"291","author":"R Marty-Roix","year":"2016","unstructured":"Marty-Roix R, Vladimer GI, Pouliot K, Weng D, Buglione-Corbett R, West K, et al. Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants. J Biol Chem. 2016;291:1123\u201336.","journal-title":"J Biol Chem"},{"key":"5755_CR136","first-page":"279","volume":"18","author":"AA Mehrizi","year":"2021","unstructured":"Mehrizi AA, Verjani SB, Zakeri S. Advax, as a co-adjuvant, in combination with Poly(I:C) elicits enhanced Th1 immune responses and parasite growth-inhibitory antibodies against Plasmodium falciparum merozoite surface protein-1 (PfMSP-142) in BALB\/c mice. Iran J Immunol. 2021;18:279\u201391.","journal-title":"Iran J Immunol"},{"key":"5755_CR137","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.1016\/j.vaccine.2017.10.012","volume":"35","author":"R Perraut","year":"2017","unstructured":"Perraut R, Varela M-L, Joos C, Diouf B, Sokhna C, Mbengue B, et al. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Vaccine. 2017;35:6720\u20136.","journal-title":"Vaccine"},{"key":"5755_CR138","doi-asserted-by":"publisher","first-page":"00645","DOI":"10.1128\/IAI.00645-20","volume":"89","author":"F Shen","year":"2021","unstructured":"Shen F, Ong JJY, Sun Y, Lei Y, Chu R, Kassegne K, et al. A chimeric Plasmodium vivax merozoite surface protein antibody recognizes and blocks erythrocytic P. cynomolgi berok merozoites in vitro. Infect Immun. 2021;89:00645\u201320.","journal-title":"Infect Immun"},{"key":"5755_CR139","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/imm.12226","volume":"141","author":"SC Elias","year":"2014","unstructured":"Elias SC, Choudhary P, Cassan SC, Biswas S, Collins KA, Halstead FD, et al. Analysis of human B cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628\u201344.","journal-title":"Immunology"},{"key":"5755_CR140","first-page":"1","volume":"13","author":"S Mahmoudi","year":"2018","unstructured":"Mahmoudi S, Keshavarz H. Malaria vaccine development: the need for novel approaches: a review article. Iran J Parasitol. 2018;13:1\u201310.","journal-title":"Iran J Parasitol"},{"key":"5755_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-017-0295-0","volume":"15","author":"CP Karch","year":"2017","unstructured":"Karch CP, Doll TAPF, Paulillo SM, Nebie I, Lanar DE, Corradin G, et al. The use of a P falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria. J Nanobiotechnology. 2017;15:1\u201310.","journal-title":"J Nanobiotechnology"},{"key":"5755_CR142","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.3389\/fimmu.2018.02780","volume":"9","author":"F Brod","year":"2018","unstructured":"Brod F, Miura K, Taylor I, Li Y, Marini A, Salman AM, et al. Combination of RTS, S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice. Front immunol. 2018;9:2780.","journal-title":"Front immunol"},{"key":"5755_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694759","volume":"12","author":"H De Graaf","year":"2021","unstructured":"De Graaf H, Payne RO, Taylor I, Miura K, Long CA, Elias SC, et al. Safety and immunogenicity of ChAd63\/MVA Pfs25-IMX313 in a phase I first-in-human trial. Front immunol. 2021;12:694759.","journal-title":"Front immunol"},{"key":"5755_CR144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"S-M Lee","year":"2020","unstructured":"Lee S-M, Hickey JM, Miura K, Joshi SB, Volkin DB, King CR, et al. A C-terminal Pfs48\/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system. Sci Rep. 2020;10:1\u201314.","journal-title":"Sci Rep"},{"key":"5755_CR145","doi-asserted-by":"publisher","first-page":"16833","DOI":"10.1038\/s41598-019-53208-z","volume":"9","author":"L Yenkoidiok-Douti","year":"2019","unstructured":"Yenkoidiok-Douti L, Williams AE, Canepa GE, Molina-Cruz A, Barillas-Mury C. Engineering a virus-like particle as an antigenic platform for a Pfs47-targeted malaria transmission-blocking vaccine. Sci Rep. 2019;9:16833.","journal-title":"Sci Rep"},{"key":"5755_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03368-5","volume":"19","author":"W-C Huang","year":"2020","unstructured":"Huang W-C, Deng B, Mabrouk MT, Seffouh A, Ortega J, Long C, et al. Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose. Malar J. 2020;19:1\u201312.","journal-title":"Malar J"},{"key":"5755_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2773-3","volume":"18","author":"S Pirahmadi","year":"2019","unstructured":"Pirahmadi S, Zakeri S, Mehrizi AA, Djadid ND, Raz A-A, Sani JJ, et al. Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi. Malar J. 2019;18:1\u201316.","journal-title":"Malar J"},{"key":"5755_CR148","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41541-021-00309-4","volume":"6","author":"NG Bender","year":"2021","unstructured":"Bender NG, Khare P, Martinez J, Tweedell RE, Nyasembe VO, L\u00f3pez-Guti\u00e9rrez B, et al. Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen. NPJ Vaccines. 2021;6:49.","journal-title":"NPJ Vaccines"},{"key":"5755_CR149","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96381","volume":"2","author":"RO Payne","year":"2017","unstructured":"Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, et al. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. JCI Insight. 2017;2:e96381.","journal-title":"JCI Insight"},{"key":"5755_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-3141-z","volume":"19","author":"J Molina-Franky","year":"2020","unstructured":"Molina-Franky J, Cuy-Chaparro L, Camargo A, Reyes C, G\u00f3mez M, Salamanca DR, et al. Plasmodium falciparum pre-erythrocytic stage vaccine development. Malar J. 2020;19:1\u201318.","journal-title":"Malar J"},{"key":"5755_CR151","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93683","volume":"2","author":"RO Payne","year":"2017","unstructured":"Payne RO, Silk SE, Elias SC, Milne KH, Rawlinson TA, Llewellyn D, et al. Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies. JCI Insight. 2017;2:e93683.","journal-title":"JCI Insight"},{"key":"5755_CR152","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1080\/21645515.2021.1947762","volume":"17","author":"MB Laurens","year":"2021","unstructured":"Laurens MB. Novel malaria vaccines. Hum Vaccines Immunother. 2021;17:4549\u201352.","journal-title":"Hum Vaccines Immunother"},{"key":"5755_CR153","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.1016\/j.vaccine.2017.02.040","volume":"35","author":"L Seth","year":"2017","unstructured":"Seth L, Ferlez KMB, Kaba SA, Musser DM, Emadi S, Matyas GR, et al. Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite protein delivered in three army liposome formulation adjuvants. Vaccine. 2017;35:5448\u201354.","journal-title":"Vaccine"},{"key":"5755_CR154","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/vaccines9020103","volume":"9","author":"CG Schneider","year":"2021","unstructured":"Schneider CG, Taylor JA, Sibilo MQ, Miura K, Mallory KL, Mann C, et al. Orientation of antigen display on self-assembling protein nanoparticles influences immunogenicity. Vaccines. 2021;9:103.","journal-title":"Vaccines"},{"key":"5755_CR155","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2019.00331","volume":"10","author":"KL Wilson","year":"2019","unstructured":"Wilson KL, Pouniotis D, Hanley J, Xiang SD, Ma C, Coppel RL, et al. A synthetic nanoparticle based vaccine approach targeting MSP4\/5 is immunogenic and induces moderate protection against murine blood-stage malaria. Front Immunol. 2019;10:331.","journal-title":"Front Immunol"},{"key":"5755_CR156","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/vaccines8040651","volume":"8","author":"L Powles","year":"2020","unstructured":"Powles L, Wilson KL, Xiang SD, Coppel RL, Ma C, Selomulya C, et al. Pullulan-coated iron oxide nanoparticles for blood-stage malaria vaccine delivery. Vaccines. 2020;8:651.","journal-title":"Vaccines"},{"key":"5755_CR157","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1016\/j.vaccine.2018.09.037","volume":"37","author":"M Burkhardt","year":"2019","unstructured":"Burkhardt M, Reiter K, Nguyen V, Suzuki M, Herrera R, Duffy PE, et al. Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A. Vaccine. 2019;37:5762\u20139.","journal-title":"Vaccine"},{"key":"5755_CR158","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jnnp.2011.241802","volume":"11","author":"JMS Pearce","year":"2011","unstructured":"Pearce JMS. Disease, diagnosis or syndrome? Pract Neurol. 2011;11:91\u20137.","journal-title":"Pract Neurol"},{"key":"5755_CR159","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.1944.02850020001001","volume":"124","author":"H Most","year":"1944","unstructured":"Most H. Falciparum malaria. JAMA. 1944;124:71\u20136.","journal-title":"JAMA"},{"key":"5755_CR160","volume":"4","author":"Z Bisoffi","year":"2012","unstructured":"Bisoffi Z, Gobbi F, Buonfrate D, den Ende J, van. Diagnosis of malaria infection with or without disease. JAMA. 2012;4:e2012036.","journal-title":"JAMA"},{"key":"5755_CR161","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/0049475515622861","volume":"46","author":"VN Orish","year":"2016","unstructured":"Orish VN, Ansong JY, Onyeabor OS, Sanyaolu AO, Oyibo WA, Iriemenam NC. Overdiagnosis and overtreatment of malaria in children in a secondary healthcare centre in Sekondi-Takoradi. Ghana Trop Doct. 2016;46:191\u20138.","journal-title":"Ghana Trop Doct"},{"key":"5755_CR162","first-page":"194","volume":"45","author":"CB Cunha","year":"2008","unstructured":"Cunha CB, Cunha BA. Brief history of the clinical diagnosis of malaria: from Hippocrates to Osler. J Vector Borne Dis. 2008;45:194\u20139.","journal-title":"J Vector Borne Dis"},{"key":"5755_CR163","first-page":"1","volume":"914675","author":"OO Oladosu","year":"2013","unstructured":"Oladosu OO, Oyibo WA. Overdiagnosis and overtreatment of malaria in children that presented with fever in Lagos. Nigeria ISRN Infect Dis. 2013;914675:1\u20136.","journal-title":"Nigeria ISRN Infect Dis"},{"key":"5755_CR164","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1365-3156.2004.01278.x","volume":"9","author":"B Fleischer","year":"2004","unstructured":"Fleischer B. Editorial: 100 years ago: Giemsa\u2019s solution for staining of plasmodia. Trop Med Int Health. 2004;9:755\u20136.","journal-title":"Trop Med Int Health"},{"key":"5755_CR165","first-page":"1","volume":"7","author":"WH Organization","year":"2016","unstructured":"Organization WH. Giemsa staining of malaria blood films malaria microscopy standard operating procedure-MM-SOP-07A 1. Purpose And Scope. 2016;7:1\u20136.","journal-title":"Purpose And Scope"},{"key":"5755_CR166","first-page":"249","volume":"34","author":"MA Dowling","year":"1966","unstructured":"Dowling MA, Shute GT. A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia. Bull World Health Organ. 1966;34:249\u201367.","journal-title":"Bull World Health Organ"},{"key":"5755_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-10-194","volume":"10","author":"D Lenz","year":"2011","unstructured":"Lenz D, Kremsner PG, Lell B, Biallas B, Boettcher M, Mordm\u00fcller B, et al. Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon. Malar J. 2011;10:1\u20136.","journal-title":"Malar J"},{"key":"5755_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2214-8","volume":"17","author":"M Kimura","year":"2018","unstructured":"Kimura M, Teramoto I, Chan CW, Idris ZM, Kongere J, Kagaya W, et al. Improvement of malaria diagnostic system based on acridine orange staining. Malar J. 2018;17:1\u20136.","journal-title":"Malar J"},{"key":"5755_CR169","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0140-6736(91)92159-Y","volume":"337","author":"F Kawamoto","year":"1991","unstructured":"Kawamoto F. Rapid diagnosis of malaria by fluorescence microscopy with light microscope and interference filter. The Lancet. 1991;337:200\u20132.","journal-title":"The Lancet"},{"key":"5755_CR170","doi-asserted-by":"publisher","first-page":"1900138","DOI":"10.1002\/bies.201900138","volume":"42","author":"B Gitta","year":"2020","unstructured":"Gitta B, Kilian N. Diagnosis of malaria parasites Plasmodium spp. in endemic areas: current strategies for an ancient disease. BioEssays. 2020;42:1900138.","journal-title":"BioEssays."},{"key":"5755_CR171","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4269\/ajtmh.2007.77.119","volume":"77","author":"C Wongsrichanalai","year":"2007","unstructured":"Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med. 2007;77:119\u201327.","journal-title":"Am J Trop Med"},{"key":"5755_CR172","first-page":"275","volume":"2018","author":"EI Obeagu","year":"2018","unstructured":"Obeagu EI, Chijioke UO, Ekelozie IS. Malaria rapid diagnostic test (RDTs). Ann Clin Lab Res. 2018;2018:275.","journal-title":"Ann Clin Lab Res"},{"key":"5755_CR173","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tmaid.2004.03.003","volume":"2","author":"T Jelinek","year":"2004","unstructured":"Jelinek T. Malaria self-testing by travellers: opportunities and limitations. Travel Med Infect Dis. 2004;2:143\u20138.","journal-title":"Travel Med Infect Dis"},{"key":"5755_CR174","first-page":"553","volume":"77","author":"CD Mills","year":"1999","unstructured":"Mills CD, Burgess DC, Taylor HJ, Kain KC. Evaluation of a rapid and inexpensive dipstick assay for the diagnosis of Plasmodium falciparum malaria. Bull World Health Organ. 1999;77:553\u20139.","journal-title":"Bull World Health Organ"},{"key":"5755_CR175","first-page":"1640","volume":"61","author":"MJ Thompson","year":"2000","unstructured":"Thompson MJ. Rapid \u201cdipstick\u201d assays for the detection of malaria. Am Fam Physician. 2000;61:1640\u20133.","journal-title":"Am Fam Physician"},{"key":"5755_CR176","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0035-9203(98)90730-1","volume":"92","author":"P Pieroni","year":"1998","unstructured":"Pieroni P, Mills CD, Ohrt C, Harrington MA, Kain KC. Comparison of the ParaSight\u2122-F test and the ICT Malaria Pf\u2122 test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers. Trans R Soc Trop Med Hyg. 1998;92:166\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5755_CR177","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1128\/JCM.36.1.203-206.1998","volume":"36","author":"CJ Palmer","year":"1998","unstructured":"Palmer CJ, Lindo JF, Klaskala WI, Quesada JA, Kaminsky R, Baum MK, et al. Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria. J Clin Microbiol. 1998;36:203\u20136.","journal-title":"J Clin Microbiol"},{"key":"5755_CR178","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1128\/JCM.37.8.2412-2417.1999","volume":"37","author":"E Tjitra","year":"1999","unstructured":"Tjitra E, Suprianto S, Dyer M, Currie BJ, Anstey NM. Field evaluation of the ICT malaria Pf\/Pv immunochromatographic test for detection of Plasmodium falciparum and Plasmodium vivax in patients with a presumptive clinical diagnosis of malaria in eastern Indonesia. J Clin Microbiol. 1999;37:2412\u20137.","journal-title":"J Clin Microbiol."},{"key":"5755_CR179","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/09674845.2002.11783665","volume":"59","author":"AH Moody","year":"2002","unstructured":"Moody AH, Chiodini PL. Non-microscopic method for malaria diagnosis using OptiMAL IT, a second-generation dipstick for malaria pLDH antigen detection. Br J Biomed Sci. 2002;59:228\u201331.","journal-title":"Br J Biomed Sci"},{"key":"5755_CR180","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1128\/JCM.01057-14","volume":"52","author":"M Imwong","year":"2014","unstructured":"Imwong M, Hanchana S, Malleret B, R\u00e9nia L, Day NPJ, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303\u20139.","journal-title":"J Clin Microbiol"},{"key":"5755_CR181","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1373\/clinchem.2014.237115","volume":"61","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, Wang D, Tian X, Sun Y, Sun X, Xiao N, et al. Capture and ligation probe-PCR (CLIP-PCR) for molecular screening, with application to active malaria surveillance for elimination. Clin Chem. 2015;61:821\u20138.","journal-title":"Clin Chem"},{"key":"5755_CR182","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/infdis\/168.5.1323","volume":"168","author":"KC Kain","year":"1993","unstructured":"Kain KC, Brown AE, Mirabelli L, Webster HK. Detection of Plasmodium vivax by polymerase chain reaction in a field study. J Infect Dis. 1993;168:1323\u20136.","journal-title":"J Infect Dis"},{"key":"5755_CR183","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0166-6851(93)90077-B","volume":"61","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315\u201320.","journal-title":"Mol Biochem Parasitol"},{"key":"5755_CR184","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.acc.2016.11.006","volume":"80","author":"Z Zheng","year":"2017","unstructured":"Zheng Z, Cheng Z. Advances in molecular diagnosis of malaria. Adv Clin Chem. 2017;80:155\u201392.","journal-title":"Adv Clin Chem"},{"key":"5755_CR185","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3347\/kjp.2014.52.4.377","volume":"52","author":"P Thongdee","year":"2014","unstructured":"Thongdee P, Chaijaroenkul W, Kuesap J, Na-Bangchang K. Nested-PCR and a new ELISA-based novalisa test kit for malaria diagnosis in an endemic area of Thailand. Korean J Parasitol. 2014;52:377\u201381.","journal-title":"Korean J Parasitol"},{"key":"5755_CR186","doi-asserted-by":"publisher","first-page":"0232874","DOI":"10.1371\/journal.pone.0232874","volume":"15","author":"B Okyere","year":"2020","unstructured":"Okyere B, Owusu-Ofori A, Ansong D, Buxton R, Benson S, Osei-Akoto A, et al. Point prevalence of asymptomatic Plasmodium infection and the comparison of microscopy, rapid diagnostic test and nested PCR for the diagnosis of asymptomatic malaria among children under 5 years in Ghana. PLoS ONE. 2020;15:0232874.","journal-title":"PLoS ONE"},{"key":"5755_CR187","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-4894(02)00010-3","volume":"100","author":"JC Polanco","year":"2002","unstructured":"Polanco JC, Rodr\u0131\u0301guez JA, Corredor V, Patarroyo MA. Plasmodium vivax: parasitemia determination by real-time quantitative PCR in Aotus monkeys. Exp Parasitol. 2002;100:131\u20134.","journal-title":"Exp Parasitol"},{"key":"5755_CR188","doi-asserted-by":"publisher","first-page":"56677","DOI":"10.1371\/journal.pone.0056677","volume":"8","author":"NW Lucchi","year":"2013","unstructured":"Lucchi NW, Narayanan J, Karell MA, Xayavong M, Kariuki S, DaSilva AJ, et al. Molecular diagnosis of malaria by photo-induced electron transfer fluorogenic primers: PET-PCR. PLoS ONE. 2013;8:56677.","journal-title":"PLoS ONE"},{"key":"5755_CR189","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1128\/JCM.42.3.1214-1219.2004","volume":"42","author":"F Perandin","year":"2004","unstructured":"Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, et al. Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol. 2004;42:1214\u20139.","journal-title":"J Clin Microbiol"},{"key":"5755_CR190","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1128\/JCM.01426-12","volume":"50","author":"PF Mens","year":"2012","unstructured":"Mens PF, de Bes HM, Sondo P, Laochan N, Keereecharoen L, van Amerongen A, et al. Direct blood PCR in combination with nucleic acid lateral flow immunoassay for detection of Plasmodium species in settings where malaria is endemic. J Clin Microbiol. 2012;50:3520\u20135.","journal-title":"J Clin Microbiol"},{"key":"5755_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1185-x","volume":"15","author":"DF Echeverry","year":"2016","unstructured":"Echeverry DF, Deason NA, Davidson J, Makuru V, Xiao H, Niedbalski J, et al. Human malaria diagnosis using a single-step direct-PCR based on the Plasmodium cytochrome oxidase III gene. Malar J. 2016;15:1\u201312.","journal-title":"Malar J"},{"key":"5755_CR192","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1128\/JCM.00276-11","volume":"49","author":"E Kamau","year":"2011","unstructured":"Kamau E, Tolbert LS, Kortepeter L, Pratt M, Nyakoe N, Muringo L, et al. Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of Plasmodium by amplifying RNA and DNA of the 18S rRNA genes. J Clin Microbiol. 2011;49:2946\u201353.","journal-title":"J Clin Microbiol"},{"key":"5755_CR193","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0091-679X(08)61081-X","volume":"42","author":"CJ Janse","year":"1994","unstructured":"Janse CJ, van Vianen PH. Flow cytometry in malaria detection. Methods Cell Biol. 1994;42:295\u2013318.","journal-title":"Methods Cell Biol"},{"key":"5755_CR194","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0014-4894(87)90012-9","volume":"64","author":"CJ Janse","year":"1987","unstructured":"Janse CJ, van Vianen PH, Tanke HJ, Mons B, Ponnudurai T, Overdulve JP. Plasmodium species: flow cytometry and microfluorometry assessments of DNA content and synthesis. Exp Parasitol. 1987;64:88\u201394.","journal-title":"Exp Parasitol"},{"key":"5755_CR195","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1086\/324096","volume":"33","author":"KN Jones","year":"2001","unstructured":"Jones KN, Mascia B, Waggoner-Fountain L, Pearson RD. Photo quiz. Diagnosis by automated blood analyzer. Clin Infect Dis. 2001;33:1944\u201395.","journal-title":"Clin Infect Dis"},{"key":"5755_CR196","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2257.1999.00220.x","volume":"21","author":"T H\u00e4nscheid","year":"1999","unstructured":"H\u00e4nscheid T. Diagnosis of malaria: a review of alternatives to conventional microscopy. Clin Lab Haematol. 1999;21:235\u201345.","journal-title":"Clin Lab Haematol"},{"key":"5755_CR197","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1365-2141.1999.01199.x","volume":"104","author":"B Mendelow","year":"1999","unstructured":"Mendelow B, Lyons C, Nhlangothi P, Tana M, Munster M, Wypkema E, et al. Automated malaria detection by depolarization of laser light. Br J Haematol. 1999;104:499\u2013503.","journal-title":"Br J Haematol"},{"key":"5755_CR198","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0169-4758(98)01284-8","volume":"14","author":"MT Makler","year":"1998","unstructured":"Makler MT, Piper RC, Milhous WK. Lactate dehydrogenase and the diagnosis of malaria. Parasitol Today. 1998;14:376\u20137.","journal-title":"Parasitol Today"},{"key":"5755_CR199","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2257.1998.00092.x","volume":"20","author":"YRAN Kim","year":"1998","unstructured":"Kim YRAN, Yee M, Chupp K, et al. Simultaneous differentiation and quantitation of erythroblasts and white blood cells on a high throughput clinical haematology analyser. Clin Lab Haematol. 1998;20:21\u20139.","journal-title":"Clin Lab Haematol"},{"key":"5755_CR200","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3347\/kjp.2009.47.2.93","volume":"47","author":"N Tangpukdee","year":"2009","unstructured":"Tangpukdee N, Duangdee C, Wilairatana P, Krudsood S. Malaria diagnosis: a brief review. Korean J Parasitol. 2009;47:93\u2013102.","journal-title":"Korean J Parasitol"},{"key":"5755_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-6-19","volume":"6","author":"C Doderer","year":"2007","unstructured":"Doderer C, Heschung A, Guntz P, Cazenave J-P, Hansmann Y, Senegas A, et al. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Malar J. 2007;6:1\u20138.","journal-title":"Malar J"},{"key":"5755_CR202","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1586\/14737159.2014.888313","volume":"14","author":"MLY Sin","year":"2014","unstructured":"Sin MLY, Mach KE, Wong PK, Liao JC. Advances and challenges in biosensor-based diagnosis of infectious diseases. Expert Rev Mol Diagn. 2014;14:225\u201344.","journal-title":"Expert Rev Mol Diagn"},{"key":"5755_CR203","first-page":"0005029","volume":"10","author":"Y Alnasser","year":"2016","unstructured":"Alnasser Y, Ferradas C, Clark T, Calderon M, Gurbillon A, Gamboa D, et al. Colorimetric detection of Plasmodium vivax in urine using MSP10 oligonucleotides and gold nanoparticles. Plos Negl Trop Dis. 2016;10:0005029.","journal-title":"Plos Negl Trop Dis"},{"key":"5755_CR204","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1039\/C7LC00758B","volume":"18","author":"N Kolluri","year":"2018","unstructured":"Kolluri N, Klapperich CM, Cabodi M. Towards lab-on-a-chip diagnostics for malaria elimination. Lab Chip. 2018;18:75\u201394.","journal-title":"Lab Chip"},{"key":"5755_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1222-9","volume":"15","author":"M Rubio","year":"2016","unstructured":"Rubio M, Bassat Q, Estivill X, Mayor A. Tying malaria and microRNAs: from the biology to future diagnostic perspectives. Malar J. 2016;15:1\u201314.","journal-title":"Malar J"},{"key":"5755_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03283-9","volume":"19","author":"D Selvarajah","year":"2020","unstructured":"Selvarajah D, Naing C, Htet NH, Mak JW. Loop-mediated isothermal amplification (LAMP) test for diagnosis of uncomplicated malaria in endemic areas: a meta-analysis of diagnostic test accuracy. Malar J. 2020;19:1\u201310.","journal-title":"Malar J"},{"key":"5755_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100347","volume":"22","author":"R Kumar","year":"2020","unstructured":"Kumar R, Verma AK, Shrivas S, Thota P, Singh MP, Rajasubramaniam S, et al. First successful field evaluation of new, one-minute haemozoin-based malaria diagnostic device. EClinicalMedicine. 2020;22:100347.","journal-title":"EClinicalMedicine"},{"key":"5755_CR208","first-page":"1","volume":"1","author":"G Garcia","year":"2022","unstructured":"Garcia G, Lord A, Chaves L, Lima-Junior J, Sikulu-Lord M. First report of rapid, non-invasive, and reagent-free detection of malaria through the skin of patients with a beam of infrared light. Res Sq. 2022;1:1\u201319.","journal-title":"Res Sq"},{"key":"5755_CR209","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","volume":"12","author":"TK Tan","year":"2021","unstructured":"Tan TK, Rijal P, Rahikainen R, Keeble AH, Schimanski L, Hussain S, et al. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun. 2021;12:542.","journal-title":"Nat Commun"},{"key":"5755_CR210","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/vaccines9070726","volume":"9","author":"NL Warner","year":"2021","unstructured":"Warner NL, Frietze KM. Development of bacteriophage virus-like particle vaccines displaying conserved epitopes of dengue virus non-structural protein 1. Vaccines. 2021;9:726.","journal-title":"Vaccines"},{"key":"5755_CR211","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","volume":"21","author":"AJ Pollard","year":"2021","unstructured":"Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021;21:83\u2013100.","journal-title":"Nat Rev Immunol"},{"key":"5755_CR212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1454-8","volume":"15","author":"D Bell","year":"2016","unstructured":"Bell D, Fleurent AE, Hegg MC, Boomgard JD, McConnico CC. Development of new malaria diagnostics: matching performance and need. Malar J. 2016;15:1\u201312.","journal-title":"Malar J"},{"key":"5755_CR213","doi-asserted-by":"publisher","first-page":"2004101","DOI":"10.1002\/advs.202004101","volume":"8","author":"M Giacometti","year":"2021","unstructured":"Giacometti M, Milesi F, Coppadoro PL, Rizzo A, Fagiani F, Rinaldi C, et al. A lab-on-chip tool for rapid, quantitative, and stage-selective diagnosis of malaria. Adv Sci. 2021;8:2004101.","journal-title":"Adv Sci"},{"key":"5755_CR214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002380","volume":"14","author":"J Hemingway","year":"2016","unstructured":"Hemingway J, Shretta R, Wells TNC, Bell D, Djimd\u00e9 AA, Achee N, et al. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14:e1002380.","journal-title":"PLoS Biol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05755-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05755-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05755-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T12:03:59Z","timestamp":1681473839000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05755-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5755"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05755-8","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}